Other factors which involve a lack of information and potentially contribute to heterogeneity include concomitant illnesses and medications, both of which may affect antioxidant status
Examples are MTHFR variants, which impact folate metabolism and homocysteine, FTO and MC4R, which are associated with weight regulation, CYP19A1, which is involved in aromatase and estrogen balance, ESR1 and ESR2, which are estrogen receptors, and variants in FSHR and LHCGR that alter ovarian response
Clin Endocrinol (Oxf) 101(6):669681
, , , , ,
They include: asymptomatic hyperuricemia (high uric acid level before the first attack) acute gout interval gout (the time between attacks) chronic gout The most common areas of the body to develop gout are the joints of the knee, ankle, and big toe
In this Perspective, we propose that inhibition of ferroptosis by GPx4 provides protective mechanisms against neurodegeneration